Proteomic Approaches in Drug Discovery and Development
- 18 October 2004
- book chapter
- Published by Elsevier
- Vol. 61, 97-126
- https://doi.org/10.1016/s0074-7742(04)61005-1
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Fluorobodies combine GFP fluorescence with the binding characteristics of antibodiesNature Biotechnology, 2003
- Signal pathway profiling of prostate cancer using reverse phase protein arraysProteomics, 2003
- A Correlation between a Proteomic Evaluation and Conventional Measurements in the Assessment of Renal Proximal Tubular ToxicityToxicological Sciences, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- “Fishing” for the functional proteomeNature Biotechnology, 2002
- Proteomic profiling of mechanistically distinct enzyme classes using a common chemotypeNature Biotechnology, 2002
- Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's diseaseNeuroscience Letters, 2000
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- A novel genetic system to detect protein–protein interactionsNature, 1989
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984